Fulcrum Therapeutics, Inc. (FULC)
10.13
-0.25
(-2.41%)
USD |
NASDAQ |
Jan 16, 16:00
10.13
0.00 (0.00%)
After-Hours: 20:00
Fulcrum Therapeutics SG&A Expense (TTM): 29.10M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Agios Pharmaceuticals, Inc. | 180.37M |
| Biogen, Inc. | 2.431B |
| CorMedix, Inc. | 75.56M |
| Apellis Pharmaceuticals, Inc. | 524.64M |
| NovaBay Pharmaceuticals, Inc. | 8.584M |